|Articles|December 17, 2009

Decoding Cancer

Alasdair Matheson spoke to Andrew J. Thompson from The Institute of Cancer Research (ICR) and Anthony Sullivan from Thermo Fisher Scientific about the role of proteomics in cancer research.

Alasdair Matheson spoke to Andrew J. Thompson from The Institute of Cancer Research (ICR) and Anthony Sullivan from Thermo Fisher Scientific about the role of proteomics in cancer research.

Click here for the full article in The Column

Newsletter

Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.

Subscribe Now!

Decoding Cancer

Newsletter

Related Content

Chromatography-Based Metabolomic Insights for Safer Kimchi Fermentation

Volatile Organic Compound Profiling of Commercial Kombucha Using GC-TOF-MS and GC×GC-TOF-MS

A Question of Balance? Part III: Weighing Isn’t an Uncertain Process, Is It?

Microflow LC–IM–QTOF Proteomics for Detecting Nut Adulteration in Walnut Products

Best of the Week: The Industry–Academia Collaboration, Sample Injection Troubleshooting

Trending on LCGC International

Volatile Organic Compound Profiling of Commercial Kombucha Using GC-TOF-MS and GC×GC-TOF-MS

A Question of Balance? Part III: Weighing Isn’t an Uncertain Process, Is It?

The 2026 LCGC Lifetime Achievement and Emerging Leader in Chromatography Awards

Leaks and Obstructions: Troubleshooting Common Problems Close to the Point of Sample Injection

Deep In The Heart of Texas: Pittcon 2026